Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical evaluation of HY-CBD anti-acne gel for inflammatory acne
TCTR20250507005Phase 0Completed
- Sponsor
- Nabsolute
- Start
- Feb 2023
- Countries
- 1
01
Overview
Phase 0, single-arm trial in acne vulgaris, sponsored by Nabsolute. Primary endpoints: Reduction in number of acne lesions and Reduction in severity of inflammatory acne. Started Feb 2023; status: completed.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20250507005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250507005.